Spineway SA (EPA:ALSPW)
France · Delayed Price · Currency is EUR 0.1590
+0.0044 (2.85%)
At close: Mar 27, 2026
Spineway Revenue
In the year 2025, Spineway had annual revenue of 12.43M EUR, down -2.38%. Spineway had revenue of 6.70M in the half year ending December 31, 2025, with 25.76% growth.
Revenue
12.43M
Revenue Growth
-2.38%
P/S Ratio
0.25
Revenue / Employee
289.07K
Employees
43
Market Cap
3.17M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 12.43M | -303.00K | -2.38% |
| Dec 31, 2024 | 12.73M | 1.38M | 12.11% |
| Dec 31, 2023 | 11.36M | 2.71M | 31.34% |
| Dec 31, 2022 | 8.65M | 3.61M | 71.76% |
| Dec 31, 2021 | 5.04M | 523.00K | 11.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 46.72B |
| EssilorLuxottica Société anonyme | 28.49B |
| Ipsen | 3.93B |
| Sartorius Stedim Biotech | 2.97B |
| IntegraGen | 6.61M |
| AMA Corporation | 2.38M |
| Plant Advanced Technologies | 2.22M |
| Aton | 656.93K |